跳至主要内容
临床试验/NCT05299606
NCT05299606终止不适用

A Prospective Multicenter Study of Transbronchial Microwave Ablation Using Robotic-Assisted Bronchoscopy in Subjects With Oligometastatic Tumors in the Lung

Ethicon, Inc.18 个研究点 分布在 3 个国家目标入组 12 人开始时间: 2022年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Ethicon, Inc.
入组人数
12
试验地点
18
主要终点
Number of Patients Whose Ablation Resulted in Technique Efficacy

研究概览

简要总结

This is a prospective, multicenter, single-arm study on transbronchial microwave ablation using the NEUWAVE FLEX Microwave Ablation System and Accessories on oligometastatic tumors in the peripheral lung, guided by the Auris MONARCH Platform for visualization and access while using cone beam CT (computed tomography) to confirm probe tip placement and final ablation zone. The primary endpoint is Technique Efficacy, assessed 30-days post-ablation via CT imaging.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Patients Whose Ablation Resulted in Technique Efficacy

时间窗: 30 days post-ablation

Technique Efficacy is defined as ablation of the target tumor(s) with the ablation zone completely overlapping or encompassing the entire target tumor(s) as assessed using CT imaging 30 days (- 7 to +14 days) after the ablation procedure.

次要结局

  • Number of Patients Whose Ablation Resulted in Technical Success(Immediately post-ablation (Day 0))
  • Number of Patients Who Experienced Local Tumor Progression(Assessed at 3 months, 6 months and 1 year post-ablation)
  • Number of Patients Who Experienced Disease Progression(Assessed at 3 months, 6 months and 1 year post-ablation)
  • Number of Patients Who Required Repeat Ablation of Target Lesion(Assessed at 3 months, 6 months and 1 year post-ablation)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验